APA

Mueller O., Chang E., Deng D., Franz T., Jing D., Kincaid R., Konigshofer Y., Kratzmeier M., McNulty M., Qian H., Schneider J., Schulte H., Seedorf U., Tian X., Van Cleve M., Yang D. & Assmann G. (20080731). PROCAM Study: risk prediction for myocardial infarction using microfluidic high-density lipoprotein (HDL) subfractionation is independent of HDL cholesterol. : Clinical chemistry and laboratory medicine.

Chicago

Mueller Odilo, Chang Elaine, Deng David, Franz Torsten, Jing Debra, Kincaid Robert, Konigshofer Yves, Kratzmeier Martin, McNulty Michael, Qian Hao, Schneider Juergen, Schulte Helmut, Seedorf Udo, Tian Xioadan, Van Cleve Mark, Yang Dorothy and Assmann Gerd. 20080731. PROCAM Study: risk prediction for myocardial infarction using microfluidic high-density lipoprotein (HDL) subfractionation is independent of HDL cholesterol. : Clinical chemistry and laboratory medicine.

Harvard

Mueller O., Chang E., Deng D., Franz T., Jing D., Kincaid R., Konigshofer Y., Kratzmeier M., McNulty M., Qian H., Schneider J., Schulte H., Seedorf U., Tian X., Van Cleve M., Yang D. and Assmann G. (20080731). PROCAM Study: risk prediction for myocardial infarction using microfluidic high-density lipoprotein (HDL) subfractionation is independent of HDL cholesterol. : Clinical chemistry and laboratory medicine.

MLA

Mueller Odilo, Chang Elaine, Deng David, Franz Torsten, Jing Debra, Kincaid Robert, Konigshofer Yves, Kratzmeier Martin, McNulty Michael, Qian Hao, Schneider Juergen, Schulte Helmut, Seedorf Udo, Tian Xioadan, Van Cleve Mark, Yang Dorothy and Assmann Gerd. PROCAM Study: risk prediction for myocardial infarction using microfluidic high-density lipoprotein (HDL) subfractionation is independent of HDL cholesterol. : Clinical chemistry and laboratory medicine. 20080731.